Clinical trial
An Integrated Model to Increase Medication Recognition and Reconciliation in Oncologic Patients
NCT04796142 is registered in ClinicalTrials.gov with Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Integrated Model to Increase Medication Recognition and Reconciliation in Oncologic Patients
- Lead sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 12, 2019
- Completion date
- September 15, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
medication reconciliation